Compare McKesson Corporation (MCK) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Recursion Pharmaceuticals Inc — how do they compare? McKesson Corporation trades at $895 (market cap $105.14B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: McKesson Corporation is far larger — about 58.1× Recursion Pharmaceuticals Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| MCK | RXRX | |
|---|---|---|
Market Cap | $105.14B | $1.81B |
Sector | Health | Health |
52-Week High | $995.69 | $6.79 |
52-Week Low | $659.01 | $2.84 |
Enterprise Value | $111.67B | $1.33B |
Dividend Yield | 0.42% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
